3/10 · Low — ~2% forward revenue CAGR; the only "growth" event is the WBD acquisition, an M&A bet, not organic acceleration
Technicals
Downtrend — $10.39, −47% off 52-wk high, below the 200-DMA, RSI 48, −20% 12-mo (SPY +21%)
Conviction
None — 0 expert voices, 0 traceable claims in the Synthos KB
Position sizing
Not a core holding; special-situation/speculative sizing only, 0–1% if at all
Next catalyst
2026-07-30 Q2'26 earnings (Street EPS $0.16); the real catalyst is WBD deal close, targeted end-Q3'26
Single biggest risk
The $59B-financed Warner Bros. Discovery acquisition — leverage, integration, and regulatory approval all in one bet
One-line thesis. Paramount Skydance is a levered media turnaround — flat ~$29–30B revenue, a secular linear-TV decline being partly offset by a streaming (Paramount+/Pluto) ramp and a real $3B+ cost-out program — but the stock is dominated by one binary: the pending, debt-heavy Warner Bros. Discovery acquisition. Until the combined entity's balance sheet and integration path are visible, this is a Watch, not an own.
◆ Synthos call — HoldPSKY is a solid business largely reflected at ~$10 — fine to keep, no reason to chase; it gets interesting again below ~$8.
Downside Risk (lower = safer)
8/10 · Very High
High leverage (net debt/adj-EBITDA ~3× pre-WBD), beta 1.44, −90% max drawdown, GAAP losses, and a transformational $59B merger overhang.
Growth Quality
3/10 · Low
~2% forward revenue CAGR, secular linear-TV decline, thin/negative GAAP margins; only cost-out and DTC mix are improving.
Exponential Potential
3/10 · Low
Not an exponential — it is a levered turnaround/merger-arb; the only "acceleration" is the WBD deal, which is an event, not organic growth.
What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.
Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.
WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.
HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.
AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.
In plain English
Paramount Skydance owns CBS, Paramount Pictures, Paramount+, Pluto TV, Nickelodeon, MTV, Comedy Central and BET. It makes money three ways: ads, subscriptions/affiliate fees from cable and streaming, and movies. The old cable-TV business is shrinking as people cut the cord; streaming is growing but only recently started making money. David Ellison's Skydance took control in 2024, and the company is now trying to buy Warner Bros. Discovery — a giant deal funded mostly with borrowed money.
Is the stock cheap or expensive? On paper it looks cheap (you pay less than 1× its yearly sales), but it carries a lot of debt and doesn't reliably make a profit under standard accounting. So "cheap" here means "risky and complicated," not "bargain."
Our verdict is Watch — interesting, but too many moving parts to buy today. Wall Street agrees: the average analyst rates it a Sell, and their price target is right where the stock already trades.
Here's what our three scores mean in everyday terms:
Downside Risk 8/10 (high). Lots of debt, a jumpy stock (it has fallen ~90% from its old peak), and a huge merger that could go well or badly.
Growth Quality 3/10 (weak). Sales are barely growing and the core TV business is in slow decline; the bright spot is cost-cutting and streaming, not real growth.
Exponential Potential 3/10 (low). This is not a fast-growing tech story. The only way it "jumps" is if the Warner deal works — that's a gamble on a merger, not organic momentum.
The one big worry: the Warner Bros. Discovery acquisition. It could transform the company — or bury it in debt if the economics or approvals go the wrong way.
Solid = price · dashed = 50-day average · dotted = 200-day average · amber = 52-week high/low. Price above both averages is an uptrend.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Blue crossing above amber (bars flip green) = momentum turning up; below (bars red) = turning down. Bar height = the size of that gap.
Relative performance vs S&P 500 & its sector (XLC (sector)), set to 100 a year ago
Solid = PSKY · dashed = S&P 500 · dotted = XLC (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
Price$10.39
Market cap$11B
P/E trailing0×
P/E FY26E / FY27E16× / 13×
EV / Sales0.9×
EV / EBITDA-5.9×
Gross margin34.8%
Net margin-2.1%
Dividend yield1.92%
Beta1.442
52-wk range$9 – $20
RSI(14)48
50 / 200-DMA$10 / $13
12-mo return+-20% (SPY +21%)
Street target$10 ($10–$10)
Analyst grades8 Buy · 10 Hold · 11 Sell
FMP ratingC-
Next earnings2026-08-05
What the experts actually said 0 traceable claims on PSKY · showing the highest-conviction voices
Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.
1. What it is
Paramount Skydance Corporation (NASDAQ: PSKY) is a global media and entertainment company, formed when David Ellison's Skydance merged with the former Paramount Global (itself the old ViacomCBS). Ellison is CEO. The business runs in three pillars:
TV Media — the CBS Television Network and stations, plus cable brands (Nickelodeon, MTV, Comedy Central, BET, CBS Sports, Showtime/Paramount Network) and international channels (Network 10, Channel 5, Telefe). This is the cash-cow-in-decline: profitable but shrinking with cord-cutting.
Direct-to-Consumer (DTC) — Paramount+, Pluto TV (free ad-supported), and BET+. The growth engine; only recently EBITDA-positive.
Filmed Entertainment (Studios) — Paramount Pictures and related labels; hit-driven, lumpy.
Fiscal year ends December 31. HQ New York; ~18,600 employees; beta 1.44; controlled historically via National Amusements, now under Skydance/Ellison control.
Revenue mix (from filings):
By product (FY2024, the last clean segmentation on file): Affiliate & subscription $13.15B (45%) · Advertising $10.30B (35%) · Licensing & other $4.95B (17%) · Theatrical $0.81B (3%). The subscription/affiliate line is now the largest — the streaming pivot is visibly reshaping the mix (Affiliate & subscription was $8.4B in 2021).
By geography (FY2024): United States $23.7B (81%) · Non-US $5.5B (19%). Heavily US-centric — a domestic-advertising and domestic-cord-cutting exposure.
(FMP's latest FY2025 product/geo segmentation is not yet broken out in the file; FY2024 is the most recent clean split.)
2. The expert thesis (traceable)
There is no expert coverage of PSKY in the Synthos knowledge base.total_claims = 0, net_bullish_voices = 0. No podcast/investor-panel voice in our tracked universe has made a traceable, dated claim on this name.
That means this note carries no conviction-track signal — the verdict is entirely fundamentals- and quant-driven, built from the FMP financials, analyst estimates, the technical block, and management's own SEC-filed guidance. We will not manufacture conviction we do not have. If and when a tracked expert makes a dated claim on PSKY, this section — and the conviction rating — will be updated with a real claim_id.
For the record, the sell-side (a different, lower-weighted signal than our KB experts) is net-negative: 0 Strong-Buy, 8 Buy, 10 Hold, 11 Sell → consensus "Sell," with a price target of exactly $10 (= the current price). The Street sees no upside from here on a standalone basis.
3. Synthos scores & the Bull / Base / Bear cases
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
Score
0–10
The read
Downside Risk(lower = safer)
8 · High
Total debt $14.8B / net debt $11.5B vs guided adj-EBITDA ~$3.8B → ~3× leverage before the WBD deal adds ~$59B of financing. Beta 1.44, −89.6% max drawdown, GAAP net losses, and a merger overhang.
Growth Quality
3 · Weak
Forward revenue CAGR ~2% (FY25 $29.2B → FY30E $32.2B); secular linear-TV decline; TTM EBIT margin −17% (impairment-distorted); the only genuine improvements are cost-out and DTC mix.
Exponential Potential
3 · Low
Not an exponential. ~2% organic growth with no acceleration. The one non-linear event is the WBD acquisition — an M&A bet, not compounding. A microcap could still re-rate hard on deleveraging, hence not a 1.
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities. Because the whole story pivots on a binary merger, treat the range as unusually wide and event-driven.
Case
Key assumptions
Fair value
Bull
WBD deal closes on favorable terms; cost-out + DTC profit accelerate; adj. EPS reaches ~$1.10–1.15 (FY28E) and the market pays ~13–14× for a deleveraging, scaled streamer.
~$15 (+44%)
Base(our anchor)
Standalone execution roughly hits estimates — FY27E adj. EPS ~$0.82; a low-growth, still-levered media name earns a modest ~12–13×. Deal risk offsets deal upside.
~$10 (~flat)
Bear
Deal falls through or closes on punishing terms; ad/linear declines steepen; leverage forces dilution or distressed refinancing; adj. EPS ~$0.50 at a ~9× trough multiple.
~$5 (−52%)
Synthos fair value = the base case, ~$10 (roughly flat), with the full $5–$15 span as the honest range. This deliberately matches the Street's $10 — not because we're anchoring to it, but because our independent standalone math lands in the same place: a low-growth, high-leverage media asset is worth roughly what it trades for, and the merger genuinely cuts both ways. This is a tracked call — the Forecaster Scorecard grades it once it matures.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating multi-baggers-from-here). PSKY is neither — it is a levered turnaround with an M&A wildcard:
Forward growth: revenue CAGR FY25→FY30E ~2% ($29.2B → $32.2B). This is a no-growth top line.
Acceleration (2nd derivative): essentially flat-to-slightly-positive on revenue; the improving line is profitability, not sales — adj. EBITDA guided to $3.8B and a $3B+ efficiency program targeted through 2027 (>$2.5B run-rate by end-2026, per management). That is margin recovery, not growth acceleration.
Room to run: at an $11.3B market cap the stock could re-rate sharply on successful deleveraging or a well-received WBD integration — the "room" exists. But the driver would be a balance-sheet and M&A outcome, not a widening TAM.
The WBD event: the only non-linear lever. Combining CBS/Paramount+ with HBO Max/Warner is a genuine scale play against Netflix and Disney — but it is financed with ~$59B (a $10B debt facility plus $49B bridge syndicated to 18 banks, per the Q1'26 letter), so the combined entity is a high-leverage, high-integration-risk proposition. Upside is real; so is the wipeout tail.
Exponential Potential: Low (3/10). Own this only as a special situation — a bet on deleveraging and merger execution — never as a growth compounder. It does not belong in a Synthos "next-exponential" sleeve.
GAAP profitability is negative and volatile: FY25 GAAP EBITDA −$4.93B and net income −$6.19B (EPS −$9.32) — dominated by large goodwill/intangible impairments (goodwill fell from $10.5B to $1.6B over the year). This is a write-down of past M&A, not an operating cash burn. Read GAAP EBITDA here with heavy skepticism — it is impairment-distorted.
Adjusted / operating reality is better: Q1'26 alone posted operating income $701M and reported EPS +$0.25 (beat the $0.15 estimate); management guides FY26 to $3.8B adjusted EBITDA. The gap between −$4.9B GAAP EBITDA and +$3.8B adjusted EBITDA is almost entirely impairments — investors should track the adjusted figure and cash flow.
Cash flow: FY25 operating CF $485M, capex −$162M, FCF ~$323M (an anemic ~2.6% FCF yield). Thin but positive — the business is not burning cash operationally.
Balance sheet: total debt $14.8B, cash $3.27B, net debt $11.5B. Against guided adj-EBITDA of $3.8B that's ~3× leverage — elevated for a no-growth business, and before the WBD financing. Current ratio 1.1×.
6. Valuation — priced in or room?
On trailing GAAP numbers the multiples are meaningless (negative EPS, negative EBITDA from impairments). The honest lenses:
Sales & cash flow: EV/Sales ~0.9×, P/S 0.38×, P/FCF ~38× (FCF is thin). Cheap on sales, not on cash flow.
Forward adjusted EPS: on consensus adj. EPS the P/E runs ~16× FY26E ($0.63) → ~13× FY27E ($0.82) → ~8× FY30E ($1.28). Optically inexpensive if the earnings recovery lands — but that's a big "if" for a ~2%-growth, ~3×-levered name.
Book: P/B 0.59× — trading below stated book value, consistent with the market pricing in further impairment/merger risk.
Street targets (context, not our anchor): consensus, high, and low are all $10 — the Street sees the stock as fairly valued to slightly rich on a standalone basis, with a "Sell" grade tilt. Our base-case FV also lands at ~$10. The upside here is not a re-rating of a cheap earnings stream; it is an event (successful WBD close + deleveraging). Without that, this is a value trap risk, not a value buy.
7. Technicals (from the tech block)
Trend:down. $10.39 sits below the 200-DMA ($12.73) and roughly at the 50-DMA ($10.42). The 50 well below the 200 is a death-cross posture. MACD −0.13 (mildly negative).
Location:−47.3% off the 52-week high ($19.73), +18.2% off the 52-week low ($8.79). The stock has round-tripped a large 2025 rally. Max drawdown from peak −89.6% — a reminder of how much value this franchise has destroyed over the cycle.
Momentum: RSI(14) 47.6 — neutral, neither overbought nor oversold; no technical "buy the dip" signal.
Relative strength (the tell): PSKY −19.6% 12-mo vs SPY +20.6% and QQQ +30.3% — massive, persistent underperformance of both the market and the Nasdaq. The only bright spot is +12.3% over the last 3 months (vs SPY +13.7%) — roughly in line, not leading.
Read: technicals do not confirm a bottom. Below the 200-DMA, in a multi-year downtrend, with neutral momentum. There is no technical reason to rush; a decisive reclaim of the 200-DMA (~$12.70) on volume would be the first constructive signal.
8. Moat & competitive position
Paramount's "moat" is a library and brand portfolio — CBS, Paramount Pictures' catalog, Nickelodeon, MTV, BET, Star Trek, and the Taylor Sheridan hit machine (Landman, The Madison, Mayor of Kingstown). CBS remains a genuine broadcast asset (management notes CBS held 13 of the top-20 primetime series). But the moat is eroding structurally: linear TV is in secular decline, and in streaming Paramount+ is a sub-scale #4/#5 against Netflix, Disney+, and Amazon, competing on spend it can less afford. The strategic logic of the WBD acquisition is precisely to buy scale (HBO Max + Warner library) to close that gap — an admission that standalone scale is insufficient.
Peer set (market cap, from file): these are FMP's size-matched comps, not true strategic peers — Frontier Communications $9.6B, Interpublic $8.9B, KT Corp $8.5B, Liberty Live $9.9B, Nexstar $5.5B, New York Times $12.0B, Pearson $10.0B, Sirius XM $10.3B, TIM SA $10.4B. The relevant strategic competitors are Netflix, Disney, Warner Bros. Discovery (the target), Comcast/NBCU, and Amazon/Apple — all far larger or better-capitalized in streaming. On that field PSKY is a challenger, not a leader.
9. Management, capital allocation & guidance
Leadership: David Ellison (Skydance) is CEO after the 2024 control transaction; Andrew Brandon-Gordon is COO/Chief Strategy Officer. This is a new, founder-driven regime explicitly reshaping the company — high agency, but an unproven public-market track record at this scale.
Capital allocation: dominated by (a) the $3B+ efficiency program through 2027 and (b) the WBD acquisition financed with ~$59B (a $10B debt facility plus a $49B bridge syndicated to 18 global banks, with a portion of new equity syndicated to strategic investors). A small dividend ($0.20/yr) and minimal buyback ($92M FY25). Capital priority is clearly deleveraging + the merger, not shareholder returns.
Insider activity: the sampled window (May–Jun 2026) shows routine equity awards, RSU vesting, and tax-withholding ("F-InKind") dispositions — e.g., director Barbara Byrne awards, COO Brandon-Gordon RSU conversions. No open-market discretionary buying or alarming cluster of sales — normal comp mechanics, not a signal either way.
Management's own guidance (half-weighted — self-interested): The Q1'26 shareholder letter (SEC 8-K / EX-99, filed 2026-05-04) is a genuine earnings release and states management's own forward view: reaffirming full-year 2026 outlook of ~$30B revenue and $3.8B adjusted EBITDA; DTC revenue +11% YoY to $2.4B with Paramount+ +17%; DTC adj. EBITDA of $251M (10% margin) and "accelerating DTC revenue and profit in 2026"; $3B+ in efficiencies through 2027 (>$2.5B run-rate by end-2026); and "significant progress toward closing the WBD acquisition by end of Q3'26." These are management's self-interested words — real, dated, and material, but weighted accordingly. The credible, checkable parts are the DTC growth and cost-out; the deal-close timeline is a target, not a certainty.
10. Catalysts & what to watch
Next earnings: 2026-07-30 (Q2'26; Street EPS $0.16, revenue ~$6.87B). Watch: DTC subscriber adds and DTC margin, ad trends, and any change to the $30B/$3.8B full-year guide.
The WBD acquisition (the whole ballgame): regulatory approval, final financing terms, and the combined-entity pro-forma leverage. Targeted close end-Q3'26 — this single event dominates the equity.
Cost-out delivery: progress toward the $2.5B run-rate efficiencies by end-2026 — the clearest lever management controls.
DTC profitability inflection: sustained streaming EBITDA growth as churn/price increases play through.
Balance-sheet: any refinancing, dilution, or asset sales tied to funding the deal.
Thesis tripwires (what would change the call): WBD deal termination or a materially worse-than-expected financing/leverage structure (bearish); a clean close with credible deleveraging plan (bullish); two quarters of DTC margin backsliding; or a guide-down on the $3.8B adj-EBITDA target.
11. Key risks
Merger risk (structural, dominant): the $59B-financed WBD acquisition is binary — regulatory, financing, and integration risk all at once. A bad outcome could impair the equity badly given existing leverage.
Leverage: ~3× net-debt/adj-EBITDA before the deal; the combined entity would be materially more levered. Rising-rate or refinancing stress is a real tail.
Secular linear-TV decline: the profit engine (TV Media affiliate + advertising) is in structural erosion; DTC must scale profitably fast enough to offset it — not yet proven.
Streaming sub-scale: Paramount+ competes against far larger, better-funded platforms; content spend is a treadmill.
GAAP volatility / further impairments: FY25 already took multi-billion write-downs; more are possible if segment values keep resetting.
No expert coverage: we have zero KB conviction to lean on — the entire thesis rests on quant + fundamentals + management's own (discounted) word.
Governance/control: founder-controlled, new regime; minority holders ride along on Ellison's strategy.
12. Verdict, position sizing & monitoring
Watch. PSKY is a levered media turnaround wrapped around a company-defining merger. The standalone business is roughly fairly valued (our base FV ~$10 ≈ Street $10 ≈ current price), profitability is genuinely recovering on cost-out and DTC mix, and the library/CBS assets have real value. But the combination of ~3× leverage, ~2% revenue growth, GAAP losses, a −90% historical drawdown, a "Sell"-tilted Street, zero expert conviction, and a $59B binary merger means there is no margin of safety and no clear catalyst to underwrite today. This is a situation to study, not size into, until the WBD deal terms and combined-entity balance sheet are visible.
Sizing:not a core position. If an investor has a specific, researched merger-arb or deleveraging thesis, special-situation sizing only (0–1%). For a general portfolio: pass and watch.
Monitoring: re-underwrite on the WBD close (terms + pro-forma leverage), the Q2'26 print (2026-07-30), and cost-out delivery. A clean deal close with a credible deleveraging path could move this to a Buy — Tactical; a broken deal or a punishing financing could move it toward Avoid.
Single biggest risk: the Warner Bros. Discovery acquisition — it is simultaneously the biggest upside lever and the biggest wipeout risk. This verdict is logged as a tracked Synthos call as of 2026-07-03 at $10.39.
Provenance & disclosures
Traceability:0 KB claims, breadth 0 — there is no expert coverage of PSKY in the Synthos knowledge base, so no claim_ids are cited. This note is fundamentals- and quant-driven. Fabricated conviction is structurally impossible (claim-ID reconciliation), and we state plainly when conviction is absent.
Data as-of: fundamentals 2026-03-31 (Q1'26) · estimates & prices 2026-07-02/03 · management guidance from the SEC 8-K/EX-99 dated 2026-05-04. Forward figures are analyst consensus (FMP) or management guidance, each labeled as estimates.
GAAP caveat: FY25 GAAP EBITDA/net income are distorted by large goodwill/intangible impairments; adjusted EBITDA (~$3.8B guided) and free cash flow are the more representative operating measures.
Management caveat: the Q1'26 shareholder-letter guidance is management's own, self-interested word — half-weighted by design.
Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").